TET2 and myeloproliferative neoplasm: In addition, Song et al. analyzed 135 MPN patients by NGS and found that JAK2, ASXL1, and TET2 were frequently mutated in PMF, PV, and ET; interestingly, the comparison between mutational and cytogenetic profiles identified a possibility role in triaging and guiding different treatments (91).